ImmunoCellular Therapeutics
| Region | Nordamerika |
| ISIN | US4525362046 |
| Sektor | Biotechnologie |
| Website | http://www.imuc.com/ |
ImmunoCellular Therapeutics, Ltd. , based in Los Angeles, is developing immune-based therapies for the treatment of cancer. ImmunoCellular is focused on advancing its Stem-to-T-Cell research program, which engineers hematopoietic stem cells to generate cytotoxic T cells.
| Titel | Datum |
|---|---|
| MISC Orders LNG Dual-Fuel Suezmax Pair in Fleet Renewal Drive | vor 22 Tagen |
| MISC Posted 60% Jump In Q3 Profit To RM541 Million Despite Lower Revenue | vor 22 Tagen |
| MISC 3Q net profit rises 60%, declares dividend of eight sen per share | vor 22 Tagen |
| MISC Secures Shipbuilding Contracts For Two LNG Dual Fuel Suezmax Vessels | vor 22 Tagen |
| MISC adds two LNG dual-fuel Suezmax vessels to its fleet | vor 24 Tagen |
| Diese Aktien könnten Dich auch interessieren | |
|---|---|
| Idea Fabrik (3 Artikel) | |
| Iconic Minerals (2 Artikel) | |
| Incyte (1 Artikel) | |
| India Globalization Capital (2 Artikel) | |
| Alle anzeigen | |